Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Four investigators based at the Botnar Research Centre, NDORMS have been recently awarded National Institute for Health Research (NIHR) fellowships to further our understanding of a variety of musculoskeletal conditions and develop better methodology to support medical research.

Lead researchers (from left to right): Professor Daniel Prieto-Alhambra, Maria Dudereva, Ioana Marian, Simon Wood

The success of our researchers reflects their commitment to delivering innovative solutions to important health problems and methodological gaps, as well as the department's supportive culture at all levels.

"These four NIHR awards are a huge success to the Botnar. This demonstrates that we can provide support for our staff at different stages of their career. We are grateful to be able to provide a support network that allows the future leaders in the field to success", says Dr Sonja Pawelczyk, Botnar Research Centre Administrator at NDORMS.

Professor Daniel Prieto-Alhambra
NIHR Senior Fellowship

“This NIHR Senior Research Fellowship provides me with the space, time, and funding to continue growing as an independent researcher. In the coming five years I will leverage pseudonymised NHS computerised medical records to investigate the risk-benefit and costs of preventative therapies in older people with complex health needs. I am looking forward to improving care for these patients with our upcoming research.”

Maria Dudereva
NIHR Doctoral Fellowship

“The NIHR Doctoral Research Fellowship is a brilliant opportunity that I will use to explore how best to improve the prognosis for people with bone and joint infections, without resorting to longer courses of antibiotics, which can cause serious side effects and antibiotic resistance. These infections pose a real threat to people’s recovery and quality of life and this project will bring some much-needed solutions to this serious health problem.”

Ioana Marian
NIHR Pre-Doctoral Fellowship

“Randomised Controlled Trials using a factorial design have the advantage of assessing two or more interventions within the same research study. Such trials can therefore provide evidence of efficacy with fewer study participants than would be needed if the interventions were tested in separate trials. An important underlying assumption is that the effects of the different interventions are independent of each other. This brings specific complexity to the design, analysis and reporting of these trials. 

Having spent time providing statistical support on an ongoing factorial trial, this fellowship will enable me to really understand the challenges associated with this type of design. Ownership of a research project will also help me become a stronger candidate for a doctoral application in the statistical research field.”

Simon Wood
NIHR Pre-Doctoral Clinical Academic Fellowship

“My long term career objective was to study for a PhD and I was finally awarded the NIHR  pre-doctoral clinical research fellowship. This  will enable me to prepare a submission for a PhD looking into the physiotherapy arm of the Femoral Acetabular Impingement Trial (FAIT). The aim is  to explore why some patients responded well to conservative treatment and some didn’t and therefore identify a sub-group of patients that we can refer to physiotherapy rather than surgery.”

The NIHR is the UK’s largest funder of health and care research and aims to improve the health and wealth of the nation through research.

Similar stories

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19

Main Research

Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?

Professor Michael Dustin elected to the National Academy of Sciences

Awards Kennedy Main

Recognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.